"Matrix-M® Adjuvant in Vaccine Development"
Institutional Seminar
Event Information
| Date and Time | 2:00 PM to 3:30 PM on Wednesday, October 29th , 2025 |
|---|---|
| Venue | Auditorium, Bdlg.1 ＆ zoom |
| Speaker | Ruxandra Draghia-Akli |
| Affiliation/Position | Novavax・Executive Vice President, R&D (MD, PhD) |
| Country | USA/Sweden |
| Title | "Matrix-M® Adjuvant in Vaccine Development" |
| Organizer | 〇Lead Organizer：Ken J. Ishii（Div. Vaccine Science and International Vaccine Design Center. IMSUT） Organizer：Kei Sato（Div. Division of Systems Virology. IMSUT） |
| Additional Information | https://u-tokyo-ac-jp.zoom.us/j/82653256608?pwd=UiueCUb3zOWdGUcoSHbL1ck1YKSn1b.1 Meeting ID : 82653256608 Passcode : 313143 |
Overview
The presentation with discuss Matrix-M adjuvant, its mechanism of action, and its application both with protein-based nanoparticles and other vaccine platforms, the safety, tolerability, and immunogenicity of the Matrix M based vaccines for various antigens, data from relevant pre-clinical and clinical trials COVID-19 and influenza, and preliminary late pre-clinical data for pandemic flu influenza using different routes of administration.